We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva, Novartis, Celgene Settle Patent Lawsuit Over Generic Focalin
Teva, Novartis, Celgene Settle Patent Lawsuit Over Generic Focalin
February 5, 2010
Novartis Pharmaceuticals and Celgene have settled a patent lawsuit with Teva Pharmaceuticals USA over a generic version of the attention-deficit drug Focalin.